If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Cephalalgia

Cephalalgia

Volume 22 Issue 3, Pages 186 - 189

Published Online: 5 Jun 2002

© 2009 International Headache Society



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 51K)  | Related Articles | Citation Tracking

Treatment of cluster headache with topiramate: effects and side-effects in five patients
S Förderreuther , M Mayer & A Straube
  Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians University, Munich, Germany
Correspondence to Stefanie Förderreuther, Neurologischer Konsiliardienst, Ludwig-Maximilians-Universität, Ziemssenstr.1, 80336-Munich Germany. Tel. + 49 89 5160 2459, fax + 49 89 5160 4915, e-mail SFOE@nefo.med.uni-muenchen.de
Copyright Blackwell Science, 2002
KEYWORDS
Cluster headache • side-effects • therapy • topiramate
Förderreuther S, Mayer M & Straube A. Treatment of cluster headache with topiramate: effects and side-effects in five patients. Cephalalgia 2002; 22:186–189. London. ISSN 0333-1024

ABSTRACT

We report on clinical experience with topiramate in the prophylactic treatment of three patients with chronic and two patients with episodic, otherwise therapy-resistant, cluster headache. Patients were treated with daily doses of 75–200 mg topiramate. Topiramate was effective in three patients but proved ineffective and also caused intolerable side-effects in two patients. Topiramate may have prophylactic properties for treating cluster headache at lower doses than needed in epilepsy therapy, but its clinical value is limited due to central nervous system side-effects.


Received 24 October 2001, accepted 5 December 2001

DIGITAL OBJECT IDENTIFIER (DOI)
10.1046/j.1468-2982.2002.00339.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
Sign Up Now
Wiley Medical Twitter